Skip to content
Optionomics Free · No account needed

Earnings analysis · 10-Q

AMPG earnings analysis

Filed August 13, 2026 · Our reading of the company's report

The latest report

The supplied 10-Q excerpt does not include the income statement, balance sheet, cash-flow statement, segment disclosures, or quantitative MD&A needed to assess Q2 revenue, margins, EPS, working capital, and free cash…

Read full summary

The supplied 10-Q excerpt does not include the income statement, balance sheet, cash-flow statement, segment disclosures, or quantitative MD&A needed to assess Q2 revenue, margins, EPS, working capital, and free cash flow; those metrics are therefore null. The principal disclosed issue is that controls remained ineffective as of June 30, 2026 because of previously identified material weaknesses. The filing also discloses 7,510 shares issued for board-advisor services and a commitment to issue 800,002 shares under a consulting agreement, indicating continued reliance on equity compensation.

Read the original on SEC.gov

Gross and operating margin

How much of each revenue dollar the business keeps.

48% Gross margin Operating margin May 2024 May 2026

One point per quarterly or annual filing. Both margins are shares of that report's revenue.

How we read each report

Our analysis across the last few reports.

Read as bullish Read as bearish May 2024 Aug 2026

Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.

What stood out

  • Financial statements affirmed as fairly presented

    Management stated that the condensed consolidated financial statements fairly represent the company’s financial condition, results of operations, and cash flows for the periods presented in accordance with GAAP, despite the identified control weaknesses.

  • Remediation plan remains in progress

    The company continues its remediation plan and expects the plan to be sufficient to remediate the identified material weaknesses and strengthen internal control over financial reporting.

  • Board-advisor equity issuance

    AmpliTech issued 7,510 shares of common stock to a board advisor for services in April 2026.

  • Consulting agreement adds equity obligations

    Under a June 9, 2026 consulting agreement, 100,000 of 800,002 committed common shares had been issued by June 2026, with the remaining 700,002 shares scheduled in monthly installments beginning in October 2026.

What to watch

  • Material weaknesses remain unresolved

    As of June 30, 2026, the CEO and CFO concluded that disclosure controls and procedures were not effective because of material weaknesses in internal control over financial reporting.

  • Control remediation may require further measures

    The cited weaknesses include lack of written control documentation, ineffective information-technology general controls, and insufficient personnel resources for segregation of duties. Management stated that additional remediation measures or modifications may be necessary.

  • Further equity dilution scheduled

    The June 9, 2026 consulting agreement commits the company to issue 800,002 common shares, including 700,002 shares in monthly installments beginning in October 2026, creating potential dilution.

Management's outlook

The supplied filing excerpt contains no quantitative revenue, EPS, operating outlook, or capital-spending guidance. Numeric guidance fields are therefore left null.

Earlier filings 4

10-Q · May 13, 2026

AmpliTech reported significant progress in Q4 2026 with revenues increasing by 48.6% year-over-year to $5.35 million, although they continued to face losses with a diluted EPS of -0.14. Management highlighted strong…

10-K · March 26, 2026

AmpliTech reported a rapid top-line expansion in 2025 (quarterly sales sum of $25.0M vs $10.0M in 2024) driven by new 5G/ORAN products and MMIC releases, but profitability remains weak with large quarterly operating…

10-Q · May 15, 2025

AmpliTech reported Q1 revenue of $3,599,099, up $1,305,768 (56.9%) versus Q1 2024, with gross profit of $1,187,870. Net loss narrowed to $1,840,521 (EPS $(0.09)) from a loss of $4,655,161 (EPS $(0.48)) in Q1 2024, aided…

10-K · March 31, 2025

AmpliTech reported a weak Q4 2024 with revenue of $1,853,000, compressed gross margin to 10.7% and an operating margin of -234.5%, continuing multi-quarter negative free cash flow. Management executed a series of equity…

This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.